Arrowhead Pharmaceuticals financials at a glance

Year Year 2004 2005 2006 2007 2008 2009 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2010 2022 2023 2024
Rev. Revenue
$0.20M $0.59M $0.46M $1.21M $1.30M $3.76M $0.30M $0.15M $0.29M $0.18M $0.38M $0.16M $31.41M $16.14M $168.80M $87.99M $138.29M $0.00M $243.23M $240.74M $0.00M
GM % Gross Margin %
-183.13% 0.00% 0.00% 0.00% 0.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 0.00% 100.00% 100.00% 0.00%
OM Operating Margin
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -117.79% 0.00% 36.25% -105.87% -107.77% 0.00% -73.39% -85.16% 0.00%
EPS Earnings Per Share
$0.90 $-1.90 $-1.18 $-1.15 $-1.43 $-1.31 $-0.47 $-0.65 $0.69 $-0.84 $-1.36 $-1.67 $-1.92 $0.00
Div. Dividends
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
PR % Payout Ratio %
0 0 0 0 0 0 0 0 -0.00% 0 0 0 0 0 0 -0.00% -0.00% 0 -0.00% -0.00% 0
Sha. Shares
0m 1.36m 2.8m 3.42m 3.86m 4.29m 7.18m 10.53m 15.64m 38.71m 54.68m 59.55m 74.17m 74.83m 92.22m 100.31m 102.76m 6.28m 104.53m 106.01m 107.43m
OCF Operating Cash Flow
$-2.31M $-9.10M $-14.79M $-23.87M $-27.58M $-15.28M $-5.39M $-15.34M $-19.03M $-35.42M $-65.71M $-64.43M $-23.94M $-47.22M $173.04M $-95.39M $171.31M $-7.70M $-136.13M $-153.89M $0.00M
FCF Free Cash Flow
$-2.98M $-9.77M $-15.52M $-24.63M $-28.26M $-15.32M $-5.40M $-15.82M $-19.33M $-37.13M $-67.68M $-68.29M $-31.86M $-48.64M $161.03M $-107.34M $147.66M $0.00M $-188.91M $-330.63M $0.00M
FCFS Free Cash Flow Per Share
$-2.71 $-5.27 $-4.92 $-6.87 $-7.21 $-3.39 $-0.75 $-1.42 $-0.81 $-0.79 $-1.18 $-1.12 $-0.43 $-0.58 $1.72 $-1.07 $1.42 $-1.20 $-1.79 $-3.10 $0.00